147 related articles for article (PubMed ID: 23239055)
1. Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry.
Kobayashi H; Kotake K; Sugihara K
Int J Clin Oncol; 2014 Feb; 19(1):98-105. PubMed ID: 23239055
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.
Kobayashi H; Kotake K; Funahashi K; Hase K; Hirata K; Iiai T; Kameoka S; Kanemitsu Y; Maeda K; Murata A; Ohue M; Shirouzu K; Takahashi K; Watanabe T; Yano H; Yatsuoka T; Hashiguchi Y; Sugihara K;
J Gastroenterol; 2014 Apr; 49(4):646-54. PubMed ID: 23793379
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
Shida D; Tsukamoto S; Ochiai H; Kanemitsu Y
Ann Surg Oncol; 2018 Jan; 25(1):173-178. PubMed ID: 29063295
[TBL] [Abstract][Full Text] [Related]
4. Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database.
Furuhata T; Okita K; Nishidate T; Hirata K; Ohnishi H; Kobayashi H; Kotake K; Sugihara K;
Int J Clin Oncol; 2015 Oct; 20(5):922-7. PubMed ID: 25762168
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis.
Sato H; Maeda K; Kotake K; Sugihara K; Takahashi H
J Gastroenterol; 2016 May; 51(5):465-72. PubMed ID: 26377391
[TBL] [Abstract][Full Text] [Related]
6. New Staging System for Colorectal Cancer Patients with Synchronous Peritoneal Metastasis in Accordance with the Japanese Classification of Colorectal Carcinoma: A Multi-Institutional Study.
Noura S; Ohue M; Ito Y; Miyoshi N; Kobayashi H; Kotake K; Sugihara K
Dig Surg; 2016; 33(1):66-73. PubMed ID: 26618448
[TBL] [Abstract][Full Text] [Related]
7. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer.
Piso P; Stierstorfer K; Gerken M; Klinkhammer-Schalke M
Int J Colorectal Dis; 2018 Nov; 33(11):1559-1567. PubMed ID: 30132068
[TBL] [Abstract][Full Text] [Related]
8. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Goéré D; Glehen O; Quenet F; Guilloit JM; Bereder JM; Lorimier G; Thibaudeau E; Ghouti L; Pinto A; Tuech JJ; Kianmanesh R; Carretier M; Marchal F; Arvieux C; Brigand C; Meeus P; Rat P; Durand-Fontanier S; Mariani P; Lakkis Z; Loi V; Pirro N; Sabbagh C; Texier M; Elias D;
Lancet Oncol; 2020 Sep; 21(9):1147-1154. PubMed ID: 32717180
[TBL] [Abstract][Full Text] [Related]
9. Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids.
Radomski M; Pai RK; Shuai Y; Ramalingam L; Jones H; Holtzman MP; Ahrendt SA; Pingpank JF; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2016 Dec; 23(13):4338-4343. PubMed ID: 27401448
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the objectivity of the Japanese classification of peritoneal metastases from colorectal cancer.
Kobayashi H; Kotake K; Sugihara K;
Jpn J Clin Oncol; 2014 Oct; 44(10):898-902. PubMed ID: 25135985
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin.
Aoki T; Umekita N; Tanaka S; Noda K; Warabi M; Kitamura M
Surgery; 2008 Jun; 143(6):706-14. PubMed ID: 18549886
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
Jeon Y; Park EJ; Lim JH; Baik SH
World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum.
Shida D; Kobayashi H; Kameyama M; Hase K; Maeda K; Suto T; Itabashi M; Funahashi K; Koyama F; Ozawa H; Noura S; Ishida H; Kanemitsu Y; Kotake K; Sugihara K
Int J Clin Oncol; 2020 Feb; 25(2):330-337. PubMed ID: 31677019
[TBL] [Abstract][Full Text] [Related]
15. Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.
Simkens GA; van Oudheusden TR; Nieboer D; Steyerberg EW; Rutten HJ; Luyer MD; Nienhuijs SW; de Hingh IH
Ann Surg Oncol; 2016 Dec; 23(13):4214-4221. PubMed ID: 27027308
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
17. Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate?
Kobayashi H; Kotake K; Sugihara K
Int J Clin Oncol; 2013 Aug; 18(4):696-703. PubMed ID: 22692571
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
[TBL] [Abstract][Full Text] [Related]
19. Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases.
Hentzen JEKR; van der Plas WY; Kuipers H; Ramcharan S; Been LB; Hoogwater FJH; van Ginkel RJ; van Dam GM; Hemmer PHJ; Kruijff S
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):590-599. PubMed ID: 31806520
[TBL] [Abstract][Full Text] [Related]
20. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
